3Jemal A, Siegel R,Xu J, et al. Cancer statistics,2010 [J]. CAcancer J Clin,2010,60(5) :277-300.
4Bystrom P,Berglund A,Nygren P,et al.An explorative study onthe clinical utility of baseline and serial serum tumour markermeasurements in advanced upper gastrointestinal cancer[j].On-col Rep,2010,24(6):1645-1652.
5Kochi M,Fujii M,Kanamori N, et al.Evaluation of serum CEAand CA19-9 levels as prognostic factors in patients with gastriccancer[J].Gastric Cancer,2000,3(4) : 177-186.
6Takahashi Y, Takeuchi T, Sakamoto J, et al.The usefulness ofCEA and/or CA19-9 in monitoring for recurrence in gastriccancer patients: a prospective clinical study[J].Gastric cancer,2003,6(3):142-145.
7Whiting J?Sano T, Saka M, et al. Follow-up of gastric cancer: areview[J].Gastric Cancer,2006?9(2) !74-81.
